Collalysin in therapy of patients with limited scleroderma
A. I. Zavyalov
Kazan medical journal ›› 1986, Vol. 67 ›› Issue (5) : 379 -379.
Collalysin in therapy of patients with limited scleroderma
In the pathogenesis of scleroderma an essential role is played by intensive collagen biosynthesis, which causes the development of fibrotic-sclerotic lesions. In this connection, it is pathogenetically substantiated the use of agents, the effect of which is aimed at decreasing the synthesis and increasing the catabolism of collagen.
Zavyalov A.I.
/
| 〈 |
|
〉 |
PDF
